Repurposing hyperpolarization‐activated cyclic nucleotide‐gated channels as a novel therapy for breast cancer

Repurposing hyperpolarization‐activated cyclic nucleotide‐gated channels as a novel therapy for breast cancer

Abstract Hyperpolarization‐activated cyclic nucleotide‐gated (HCN) channels are members of the voltage‐gated cation channel family known to be expressed in the heart and central nervous system. Ivabradine, a small molecule HCN channel‐blocker, is FDA‐approved for clinical use as a heart rate‐reducin...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ka‐Chun Mok, Ho Tsoi, Ellen PS Man, Man‐Hong Leung, Ka Man Chau, Lai‐San Wong, Wing‐Lok Chan, Sum‐Yin Chan, Mai‐Yee Luk, Jessie Y.W. Chan, Jackie K.M. Leung, Yolanda H.Y. Chan, Sellma Batalha, Virginia Lau, David C.W. Siu, Terence K.W. Lee, Chun Gong, Ui‐Soon Khoo
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
ER‐stress
HCN
Ivabradine
targeted therapy
triple‐negative breast cancer
Medicine (General)
R5-920
Acceso en línea:https://doaj.org/article/89dc802a66c04d34bba35fe0b981b854
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/89dc802a66c04d34bba35fe0b981b854

Ejemplares similares